Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC–MS/MS

Ítems similars

• Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother–infant pairs
  per: Waitt, Catriona, et al.
  Publicat: (2018)
• Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS
  per: Olagunju, Adeniyi, et al.
  Publicat: (2015)
• Validation and clinical application of a method to quantify nevirapine in dried blood spots and dried breast milk spots
  per: Olagunju, Adeniyi, et al.
  Publicat: (2015)
• Validation of an LC-MS/MS Assay to Simultaneously Monitor the Intracellular Active Metabolites of Tenofovir, Emtricitabine, and Lamivudine in Dried Blood Spots
  per: Schauer, Amanda P., et al.
  Publicat: (2017)
• Quantitation of Tenofovir and Emtricitabine in Dried Blood Spots (DBS) with LC-MS/MS
  per: Zheng, Jia-Hua, et al.
  Publicat: (2013)